Advances in therapeutic treatment options for ANCA-associated vasculitis

被引:6
作者
Carpenter, Shealynn [1 ]
Cohen Tervaert, Jan Willem [1 ,2 ]
Yacyshyn, Elaine [1 ]
机构
[1] Univ Alberta, Dept Med, Div Rheumatol, Edmonton, AB, Canada
[2] Maastricht Univ, Sch Mental Hlth & Neurosci, Maastricht, Netherlands
来源
EXPERT OPINION ON ORPHAN DRUGS | 2020年 / 8卷 / 04期
关键词
ANCA-associated vasculitis; drug therapy; remission induction; maintenance therapy; ANTIBODY-ASSOCIATED VASCULITIS; AZATHIOPRINE MAINTENANCE THERAPY; DAILY ORAL CYCLOPHOSPHAMIDE; TERM-FOLLOW-UP; REMISSION INDUCTION; RANDOMIZED-TRIAL; PLASMA-EXCHANGE; EOSINOPHILIC GRANULOMATOSIS; MYCOPHENOLATE-MOFETIL; CLINICAL-OUTCOMES;
D O I
10.1080/21678707.2020.1760837
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Introduction: ANCA-associated vasculitis (AAV) is a group of life-threatening autoimmune conditions that require a combination of treatments for induction and maintenance therapy. High-dose glucocorticoids and cyclophosphamide have traditionally been the mainstay of AAV treatment. During the last decade, rituximab has proven to be an effective alternative to cyclophosphamide. Currently, significant research in alternative therapeutic options for both induction and maintenance treatment is underway. Areas covered: Guideline review of remission, induction, and maintenance therapy of AAV. Examination of current research on alternative advanced therapeutics, specifically, the evidence for rituximab, C5a inhibitors, and trimethoprim-sulfamethoxazole. Expert opinion: Toxicities of existing therapies for AAV need to be limited, with alternative methods and agents for induction and maintenance. Importantly, the side-effects of high dose and long-term steroids have now been recognized. Newer induction agents and maintenance regimes will lead the future of AAV treatment.
引用
收藏
页码:127 / 136
页数:10
相关论文
共 83 条
  • [21] Mycophenolate Mofetil vs Azathioprine for Remission Maintenance in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis A Randomized Controlled Trial
    Hiemstra, Thomas F.
    Walsh, Michael
    Mahr, Alfred
    Savage, Caroline O.
    de Groot, Kirsten
    Harper, Lorraine
    Hauser, Thomas
    Neumann, Irmgard
    Tesar, Vladimir
    Wissing, Karl-Martin
    Pagnoux, Christian
    Schmitt, Wilhelm
    Jayne, David R. W.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2010, 304 (21): : 2381 - 2388
  • [22] Proteinase 3-ANCA Vasculitis versus Myeloperoxidase-ANCA Vasculitis
    Hilhorst, Marc
    van Paassen, Pieter
    Tervaert, Jan Willem Cohen
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2015, 26 (10): : 2314 - 2327
  • [23] Improved outcome in anti-neutrophil cytoplasmic antibody (ANCA)-associated glomerulonephritis: a 30-year follow-up study
    Hilhorst, Marc
    Wilde, Benjamin
    van Paassen, Pieter
    Winkens, Bjorn
    Vriesman, Peter van Breda
    Tervaert, Jan Willem Cohen
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2013, 28 (02) : 373 - 379
  • [24] Huugen D, 2007, KIDNEY INT, V71, P646, DOI 10.1038/sj.ki.5002103
  • [25] A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies
    Jayne, D
    Rasmussen, N
    Andrassy, K
    Bacon, P
    Tervaert, JWC
    Dadoniene, J
    Ekstrand, A
    Gaskin, G
    Gregorini, G
    de Groot, K
    Gross, W
    Hagen, EC
    Mirapeix, E
    Pettersson, E
    Siegert, C
    Sinico, A
    Tesar, V
    Westman, K
    Pusey, C
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (01) : 36 - 44
  • [26] Randomized trial of plasma exchange or high-dosage Methylprednisolone as adjunctive therapy for severe renal vasculitis
    Jayne, David R. W.
    Gaskin, Gill
    Rasmussen, Niels
    Abramowicz, Daniel
    Ferrario, Franco
    Guillevin, Loic
    Mirapeix, Eduardo
    Savage, Caroline O. S.
    Sinico, Renato A.
    Stegeman, Coen A.
    Westman, Kerstin W.
    van der Woude, Fokko J.
    van Wijngaarden, Robert A. F. de Lind
    Pusey, Charles D.
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2007, 18 (07): : 2180 - 2188
  • [27] Randomized Trial of C5a Receptor Inhibitor Avacopan in ANCA-Associated Vasculitis
    Jayne, David R. W.
    Bruchfeld, Annette N.
    Harper, Lorraine
    Schaier, Matthias
    Venning, Michael C.
    Hamilton, Patrick
    Burst, Volker
    Grundmann, Franziska
    Jadoul, Michel
    Szombati, Istvan
    Tesar, Vladimir
    Segelmark, Marten
    Potarca, Antonia
    Schall, Thomas J.
    Bekker, Pirow
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2017, 28 (09): : 2756 - 2767
  • [28] Intravenous immunoglobulin for ANCA-associated systemic vasculitis with persistent disease activity
    Jayne, DRW
    Chapel, H
    Adu, D
    Misbah, S
    O'Donoghue, D
    Scott, D
    Lockwood, CM
    [J]. QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2000, 93 (07) : 433 - 439
  • [29] 2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides
    Jennette, J. C.
    Falk, R. J.
    Bacon, P. A.
    Basu, N.
    Cid, M. C.
    Ferrario, F.
    Flores-Suarez, L. F.
    Gross, W. L.
    Guillevin, L.
    Hagen, E. C.
    Hoffman, G. S.
    Jayne, D. R.
    Kallenberg, C. G. M.
    Lamprecht, P.
    Langford, C. A.
    Luqmani, R. A.
    Mahr, A. D.
    Matteson, E. L.
    Merkel, P. A.
    Ozen, S.
    Pusey, C. D.
    Rasmussen, N.
    Rees, A. J.
    Scott, D. G. I.
    Specks, U.
    Stone, J. H.
    Takahashi, K.
    Watts, R. A.
    [J]. ARTHRITIS AND RHEUMATISM, 2013, 65 (01): : 1 - 11
  • [30] Mycophenolate mofetil versus cyclophosphamide for remission induction in ANCA-associated vasculitis: a randomised, non-inferiority trial
    Jones, Rachel B.
    Hiemstra, Thomas F.
    Ballarin, Jose
    Blockmans, Daniel Engelbert
    Brogan, Paul
    Bruchfeld, Annette
    Cid, Maria C.
    Dahlsveen, Karen
    de Zoysa, Janak
    Espigol-Frigole, Georgina
    Lanyon, Peter
    Peh, Chen Au
    Tesar, Vladimir
    Vaglio, Augusto
    Walsh, Michael
    Walsh, Dorothy
    Walters, Giles
    Harper, Lorraine
    Jayne, David
    Salama, Alan D.
    Milford, David
    Kluth, David
    Luqmani, Raashid
    Flossmann, Oliver
    Short, Andrew
    Baildam, Eileen
    Stoves, John
    Erwig, Lars
    Christian, Martin
    Savage, Caroline O.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 (03) : 399 - 405